Skip to Main Content

Author Details

Michael Bergqvist
Umea University
1998
111
28
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36797715Use of CAM among cancer patients : Results of a regional survey in Sweden.BMC Complement Med Ther2023
34347079ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.Neuro Oncol2022
36520832Patterns of care and outcomes in immigrants with non-small cell lung cancer. A population-based study (Sweden).PLoS One2022
35012418Reply to Assoc. Prof. Kocak.Acta Oncol2022
34779354Are older patients with non-small cell lung cancer receiving optimal care? A population-based study.Acta Oncol2022
34230144Radiotherapy as Elective Treatment of the Node-negative Neck in Oral Squamous Cell Cancer.Anticancer Res2021
33715623Socioeconomy as a prognostic factor for location of death in Swedish palliative cancer patients.BMC Palliat Care2021
33714010Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer.ESMO Open2021
31350754Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010-2016 in Sweden: A nationwide observational study.Int J Cancer2020
32620630Geographical Differences in Likelihood of Home Death Among Palliative Cancer Patients: A National Population-based Register Study.Anticancer Res2020
30591470Validation of a Clinical Cancer Register at the Head and Neck Oncology Center in ÿrebro.Anticancer Res2019
30711958No Evidence for Increased Brain Tumour Incidence in the Swedish National Cancer Register Between Years 1980-2012.Anticancer Res2019
31027696Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study.Lung Cancer2019
29532282The role of income in brain tumor patients: a descriptive register-based study : No correlation between patients' income and development of brain cancer.Med Oncol2018
29846705IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas.Neuro Oncol2018
30429015Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.Lung Cancer2018
29763414CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.J Clin Invest2018
27882820Phase II randomized study of the IGF-1R pathway modulator AXL1717 compared to docetaxel in patients with previously treated, locally advanced or metastatic non-small cell lung cancer.Acta Oncol2017
28486004The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study.Acta Oncol2017
28433799Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence.Transl Oncol2017
28454474Incidence trends in high-grade primary brain tumors in males and females.Oncol Lett2017
28294576End-of-life care: Where do cancer patients want to die? A systematic review.Asia Pac J Clin Oncol2017
28445977Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression.Oncotarget2017
29118048RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer.Genes Dev2017
29096687Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells.BMC Res Notes2017
28669167The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II TrialAsian Pac J Cancer Prev2017
28895417The prognostic value of pre-treatment thrombocytosis in two cohorts of patients with non-small cell lung cancer treated with curatively intended chemoradiotherapy.Neoplasma2017
26161618A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial.Acta Oncol2016
28983366Incidence Rates in Low-Grade Primary Brain Tumors: Are There Differences Between Men and Women? A Systematic Review.World J Oncol2016
27354580The Use of Complementary and Alternative Medicine in Scandinavia.Anticancer Res2016
25383446Brain tumors in Sweden: data from a population-based registry 1999-2012.Acta Oncol2015
26408714Effect of Increased Radiotoxicity on Survival of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Radiotherapy.Anticancer Res2015
26124345Patients with Non-small Cell Lung Cancer Analyzed for EGFR: Adherence to Guidelines, Prevalence and Outcome.Anticancer Res2015
26035533[Waiting time in lung cancer care. Patient guides provided faster flow].Lakartidningen2015
25964522Randomized Trials of Systemic Medically-treated Malignant Mesothelioma: A Systematic Review.Anticancer Res2015
25794491A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer.Med Oncol2015
25263081FGF2 as a potential prognostic biomarker for proneural glioma patients.Acta Oncol2015
24166872Time trends in T3 to T4 laryngeal cancer: a population-based long-term analysis.Head Neck2014
25268364Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade.PLoS One2014
24510345PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas.Tumour Biol2014
24293407WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism.Carcinogenesis2014
24410805Subtyping of gliomas of various WHO grades by the application of immunohistochemistry.Histopathology2014
24037901A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.Int J Cancer2014
24091309Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner.Mol Oncol2014
23032747Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.Clin Cancer Res2013
23690928A texture based pattern recognition approach to distinguish melanoma from non-melanoma cells in histopathological tissue microarray sections.PLoS One2013
23736154Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.Cancer Chemother Pharmacol2013
23783486Vandetanib combined with a p38 MAPK inhibitor synergistically reduces glioblastoma cell survival.Med Oncol2013
23174948Microtubule inhibition causes epidermal growth factor receptor inactivation in oesophageal cancer cells.Int J Oncol2013
23254960The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer.Med Oncol2013
  • 1 - 50 of 111

Recommended Authors

Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year 2016
Number of shared co-authors 0
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 0
Sara Kuruvilla
Schulich School of Medicine and Dentistry, Western University
Career Start Year 2010
Number of shared co-authors 0
Bhumsuk Keam
Seoul National University Hospital
Career Start Year 2006
Number of shared co-authors 0
Iacopo Petrini
University of Pisa
Career Start Year 2006
Number of shared co-authors 0
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Daniel Morgensztern
Washington University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Fiona Blackhall
The University of Manchester
Career Start Year 2000
Number of shared co-authors 0
Chang-Qi Zhu
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1996
Number of shared co-authors 0
Ping Yang
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 0
Johan Bussink
Radboud University, Nijmegen Medical Centre
Career Start Year 1995
Number of shared co-authors 0
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 0
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 0
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 0
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 0
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Career Start Year 1992
Number of shared co-authors 0
Philippe Lambin
Maastricht University
Career Start Year 1992
Number of shared co-authors 1
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 0
Val??rie Laurence
Institut Curie
Career Start Year 1990
Number of shared co-authors 0
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 0
Roy S Herbst
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 0
Giuseppe Giaccone
Meyer Cancer Center
Career Start Year 1981
Number of shared co-authors 0
Ramaswamy Govindan
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 1981
Number of shared co-authors 0
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 0
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Career Start Year 1977
Number of shared co-authors 0
Bengt Glimelius
Uppsala University
Career Start Year 1974
Number of shared co-authors 19
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 0

Collaborators

Fredrik Pont??n
Uppsala University
Co-authored papers 22
Per-Henrik Edqvist
Uppsala University
Co-authored papers 9
Patrick Micke
Uppsala University
Co-authored papers 8
Margr??t Agnarsd??ttir
Uppsala University
Co-authored papers 7
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers 6
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Co-authored papers 6
Sara Str??mberg
Uppsala University
Co-authored papers 6
Asa Bolander
Uppsala University
Co-authored papers 5
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 4
Elton Rexhepaj
UCD Conway Institute, University College Dublin
Co-authored papers 3
Sanjay Navani
Breach Candy Hospital and Research Centre
Co-authored papers 3
Fred Nyberg
University of Gothenburg
Co-authored papers 2
Emma Lundberg (CM4AI)
Stanford University
Co-authored papers 2
Denise Ryan
UCD Conway Institute, University College Dublin
Co-authored papers 2
Karin Jirstr??m
Lund University
Co-authored papers 2
Kenneth Wester
Uppsala University
Co-authored papers 2
J??rg Rahnenf??hrer
TU Dortmund University
Co-authored papers 2
Jochen M Schwenk
KTH Royal Institute of Technology
Co-authored papers 2
Mairin Rafferty
Oncomark Ltd.
Co-authored papers 2
Kristina Magnusson
Uppsala University
Co-authored papers 2
Anna Asplund
Uppsala University
Co-authored papers 2
Dijana Djureinovic
Yale University School of Medicine
Co-authored papers 1
Caroline Kampf
Uppsala University
Co-authored papers 1
Patrick C O'Leary
University of California San Francisco
Co-authored papers 1
Johanna S M Mattsson
Uppsala University
Co-authored papers 1
Tea Dodig-Crnkovi??
Columbia University
Co-authored papers 1
Julia Bergman
Uppsala University
Co-authored papers 1
Cecilia Lindskog
Uppsala University
Co-authored papers 1
Ingrid Hedenfalk
Lund University and Skane University Hospital
Co-authored papers 1
Fredrik Wiklund
Co-authored papers 1
Release 1.2